FilingReader Intelligence

Fosun Pharma names Chen Yuqing chairman, restructures leadership

April 30, 2025 at 05:29 AM UTC•By FilingReader AI

Shanghai Fosun Pharmaceutical Group (SSE:600196) has appointed Chen Yuqing as its new chairman, effective April 29, 2025, succeeding Wu Yifang, who will remain as a non-executive director. Concurrently, Guan Xiaohui has been named co-chairman and Wen Deyong as vice-chairman. These changes come as the company reported a 7.26% YoY revenue decrease in its first quarter of 2025, with revenue of CNY 9.42 billion.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Fosun Pharma's announcement on the adjustment of the division of duties of directors and the change of chairmanApril 29, 2025 at 08:00 AM UTC

Supplementary Source Documents

Fosun Pharma's announcement on the adjustment of the division of duties of directors and the change of chairmanApril 29, 2025 at 11:45 AM UTC

Fosun Pharma's announcement on participating in the establishment of a private equity investment fund and related transactionsApril 29, 2025 at 11:45 AM UTC

Shanghai Fosun Pharmaceutical Group

SSE:600196•Shanghai Stock Exchange

PharmaceuticalsShanghai Blue Chip

RSS feed for Shanghai Fosun Pharmaceutical Group

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →